Agoracom Blog Home

Posts Tagged ‘small cap stocks’

The Roundup – @Novamind_Inc $NM.ca $NVMDF $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 10:49 AM on Saturday, May 8th, 2021

A weekly summary of Novamind news and media

FEATURES May 7, 2021

Novamind Expands Footprint of Psychedelic Clinics

Our CEO Yaron Conforti and CMO Reid Robison discuss the news of our clinic expansion and how this further develops our model for scaling across the U.S.

FEATURES May 5, 2021

Pierre Bou-Mansour Discusses the Initial Phase of Novamind’s National Expansion Strategy

Our Chief Operating Officer speaks with the Wall Street Reporter about our clinic expansion, the key drivers of our growth, and the importance of set and setting in our clinics.

View all media

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

May 4, 2021

View all press releases

A Psychedelic Drug Passes Big Test for PTSD Treatment

In a soon-to-be-published study, MDMA and therapy are showing promising results in the treatment of PTSD, with over 67 percent of participants no longer qualifying for a diagnosis two months after treatment.

Why Psychedelics, Big in the 1960s, Are Drawing New Interest Now

Long misunderstood, psychedelics are back in the spotlight as more and more research is being done on the efficacy and positive mental health benefits they hold.

Follow @novamind_inc on Instagram

 
 

For further information, contact:

Bill Mitoulas
Investor Relations
Telephone: +1 (416) 479 9547
Email: [email protected]

VIDEO – $HPQ.ca Silicon Going After $2.2 Billion Fumed Silica Market Is A “Natural Extension, Potentially Lucrative Offshoot” $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:07 PM on Tuesday, May 4th, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following:

Today, the Company announced  HPQ Silicon and Pyrogenesis Evaluating a Low-cost and Environmentally Friendly Plasma Based Process to Manufacture Fumed Silica

To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:

Combining HPQ Silicon High Purity Quartz initiatives with PyroGenesis industry leading knowhow in the development of commercial plasma processes, this new process could revolutionize the manufacturing of Fumed Silica, give HPQ and PyroGenesis a market leadership in its green manufacturing and pivot production back to North America, all the while allowing end users to improve their environmental footprint.

 Watch this great interview with $HPQ CEO Bernard Tourillon to understand why Fumed Silica is a winnable market and how far advanced they are with PyroGenesis on this initiative.

AGORACOM Small Cap 60: What Is The Importance of The $HPQ.ca Gen1 PUREVAP Nano Silicon Reactor? $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:22 PM on Tuesday, April 27th, 2021

VIDEO – $HPQ.ca Silicon Production Milestone Moves Company Closer To Awaiting Battery Manufacturers and Automobile Manufacturers HPQFF $ENPH $BE $NNO $PYR

Posted by AGORACOM-JC at 4:42 PM on Friday, April 23rd, 2021

HPQ Silicon Resources $HPQ $HPQFF is a Quebec-based company that is developing a portfolio of high value-added silicon products sought after by battery and electric vehicle manufacturers.  

If that sounds a lot like what other small companies are saying lately, $HPQ differentiates itself as a leader of the pack thanks to the following: 

Yesterday, the Company announced a major milestone with this press release HPQ Gen1 Nano Silicon Reactor Exceeds Phase 1 Production Rate Target By 67%

To discuss the importance and the implications of this milestone, this excerpt from the press release says it all:

“Once the final equipment modifications are completed, the goal of the program will be to produce qualified samples which will then be tested by a third-party, the Institut National de Recherche Scientifique (INRS), and subsequently to awaiting battery manufacturers and automobile manufacturers.”

 Peter Pascali, President and CEO of PyroGenesis added a little more excitement when he stated

“It is even more exciting when one considers the impact this could have on addressing the challenges facing the EV battery space.”

Watch this great interview with $HPQ CEO Bernard Tourillon to get the full picture on next steps!

KWESST $KWE.ca $KWEMF Announces U.S. Patent Award for Phantom(TM), Qualifies for Government Programs $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 3:07 PM on Tuesday, April 20th, 2021

Electronic decoy product advances to sponsorship and evaluation with U.S. military and another NATO nation

  • Announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy
  • This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020

Ottawa, Ontario–(April 20, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced the award of U.S. patent 10,969,467 B1 for Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy. This patent is one of the core technologies of the Company’s PhantomTM electronic decoy, as described in the press releases of October 5th and December 30th, 2020.

In conjunction with the patent award, the Company confirmed that the PhantomTM system has just been selected in defence and innovation programs for evaluation, including a U.S. Special Operations Command program, and has been prequalified for government funding with an estimated initial value of approximately $1 million once approved.

“Apart from the potential near-term dollars involved, this qualification and invitation to participate in trials with key agencies in the U.S. and another NATO country signals serious interest in the PhantomTM system,” said Jeff MacLeod, KWESST Founder, President and CEO. He adds that, “These concurrent developments also appear likely to accelerate the pace of market uptake. Accordingly, with the upcoming close of our $4 million financing announced April 9, 2021 we will be prioritizing the productization of PhantomTM to be in the market sooner than originally planned.”

The Company stated that there is growing interest among NATO and partner countries for a tactical electronic decoy to prevent adversaries from locating and targeting friendly forces. This growing interest stems from incidents like one publicly reported in the 2016 where two full Ukrainian mechanized battalions were annihilated by Russian adversaries in three minutes with precision mass fire after locating them based on their electronic signal emissions.

About the PhantomTM electronic decoy
PhantomTM is a compact, lightweight electromagnetic transmitter capable of mimicking the electromagnetic signature of a tactical military unit, fooling adversaries as to the location of NATO and partner nation forces. Recent interest from NATO agencies and defence contractors for this product has resulted in KWESST moving up the scheduled production of demonstration samples of PhantomTM in the Company’s priorities. An earlier prototype version of PhantomTM was procured and successfully trialed in military exercises. The latest version is more compact, with greater capability, and is soldier-portable or can be deployed by Unmanned Aerial Systems (“UAVs” or “drones”). Based on internal research the Company estimates the market for a system like PhantomTM to be worth several hundred million dollars in the U.S. alone.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/759400-kwesst-announces-u-s-patent-award-for-phantom-tm-qualifies-for-government-programs/messages/2312755#message

MedX Health $MDX.ca to Present at the Planet MicroCap Virtual Event on April 22, 2021 $DMTK $LMD.ca $DOC.ca $DOCRF $WELL.ca $PRN.ca

Posted by AGORACOM-JC at 12:34 PM on Tuesday, April 20th, 2021
Home - MedX Health
  • Will present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22 nd at 12:00 PM EDT

MedX Health Corp. (TSXV: MDX) (“ MedX ” or the “ Company ”), a global leader in teledermatology, will present at the Planet MicroCap Showcase: VIRTUAL on Thursday, April 22 nd at 12:00 PM EDT.

Mike Druhan, President of Dermatology Services, will present at the event, outlining MedX’s vision for scaling access to its unique dermatological image capture technology and its fully integrated telemedicine platform, DermSecure®. Unlike other teledermatology screening tools available, MedX’s DermSecure® Screening Platform features high-resolution image capture technology for moles, lesions and other skin conditions, providing a complete, virtual dermatological assessment by a certified dermatologist within just 72 hours.

To access the live presentation, please use the following details:

Planet MicroCap Showcase: VIRTUAL 2021
Date: Thursday, April 22, 2021
Time: 12:00 PM Eastern Time
Webcast: https://www.webcaster4.com/Webcast/Page/2059/40755

To book a one-on-one investor meeting with MedX or to watch the Company’s presentation, please register for the virtual event here: https://planetmicrocapshowcase.com/signup

One-on-one meetings will be scheduled and conducted via private, secure video conference through the conference event platform.

The Planet MicroCap Showcase: VIRTUAL website is available here: https://planetmicrocapshowcase.com/

For those unable to attend the live presentation, all company presentation webcasts will be available directly on the conference event platform on this link under the tab “Agenda”: https://planetmicrocapshowcase.com/agenda

About MedX

MedX, headquartered in Mississauga, Ontario, is a leading medical device and software company focused on skin health with its SIAscopy® on DermSecure® telemedicine platform, utilizing its SIAscopy® technology. SIAscopy® is also embedded in its products SIAMETRICS™, SIMSYS™, and MoleMate™, which MedX manufactures in its ISO 13485 certified facility. SIAMETRICS™, SIMSYS™, and MoleMate™ include hand-held devices that use patented technology utilizing light and its remittance to view up to 2 mm beneath suspicious moles and lesions in a pain-free, non-invasive manner, with its software then creating real-time images for physicians and dermatologists to evaluate all types of moles or lesions within seconds. These products are Health Canada, FDA, TGA and CE cleared for use in Canada, the US, Australia, New Zealand, the European Union, Brazil and Turkey. MedX also designs, manufactures and distributes quality photobiomodulation therapeutic and dental lasers to provide drug-free and non-invasive treatment of tissue damage and pain.

www.medx.com

About SNN.Network

SNN.Network is your multimedia financial news platform for discovery, transparency and due diligence. This is your one-stop hub to find new investment ideas, check in on watchlist, gather the most up-to-date information on the Small-, Micro-, Nano-Cap market with the goal to help you towards achieving your wealth generation goals. Follow the companies you want to know more about; read and watch content from your favorite finance and investing influencers; create your own watchlist and screen for ideas you’re interested in; find out about investor conferences you want to attend – all here on SNN.Network.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210420005954/en/

Bill Mitoulas
Investor Relations
Phone: 416-479-9547
Email: [email protected]

Kontrol $KNR $KNR.ca $KNR.c $KNRLF BioCloud adds Leading Canadian Manufacturing Partner $LXG

Posted by AGORACOM-JC at 8:14 AM on Monday, April 19th, 2021
  • Announced the addition of Danby Appliances to its BioCloud manufacturing team and a manufacturing strategic partnership between Kontrol, OES Inc. and Danby
  • The strategic partnership will mean that OES will handle global supply chain, project engineering and production of the electronic components and Danby will focus on final assembly and scaling production

TORONTO , April 19, 2021 – Kontrol Technologies Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) (” Kontrol Technologies ” or ” Kontrol ” or ” Company “) a leader in smart buildings and cities through IoT, Cloud and SaaS technology, is pleased to announce the addition of Danby Appliances (” Danby “) to its BioCloud manufacturing team and a manufacturing strategic partnership between Kontrol, OES Inc. (” OES “) and Danby. The strategic partnership will mean that OES will handle global supply chain, project engineering and production of the electronic components and Danby will focus on final assembly and scaling production.

“We continue to add to the infrastructure essential to build BioCloud into a global solution for real-time viral detection,” says Paul Ghezzi , CEO Kontrol. “We’re pleased to welcome Danby, one of Canada’s leading manufacturers, to the team. It’s exciting to have them on-board and part of the plan to mass produce BioCloud in Ontario .”

Danby is a Canadian company with a long history of bringing innovative products to market.  Danby’s product manufacturing experience, existing infrastructure in Ontario , and recent success in the mass production of ventilators through the Canadian Ventilator Program will compliment OES’ expertise in product engineering and complex electronic manufacturing.

“We’re thrilled to partner with Jim Estill and his team at Danby, it’s an exciting made-in- Ontario manufacturing partnership,” says Jeff Stewart , CEO of OES Inc. “Our focus has always been centered on rapid prototype development through product launch and initial manufacturing of the technology. With the anticipated global demand for BioCloud, we knew partnering with another manufacturer experienced in large scale product assembly with existing infrastructure in Ontario to support quick ramp up would be important. “

“We are delighted to have been selected by Kontrol and OES as a strategic partner and to be participating in the production of this innovative and much needed technology,” says Jim Estill , CEO Danby.

About Danby Appliances

A proudly Canadian, privately owned company, Danby is a recognized brand and a world leader of refrigeration and specialty appliance products proudly assembling their products in Ontario, Canada . With a rich history of creating innovative appliance, refrigeration and climate control products, Danby has been at the forefront of revolutionizing smart space living for the past 75 years. Their mission is simple; create simple, functional, and durable products designed to fit consumers at every stage of their life. The combination of smart design, smart craftsmanship, and smart price has been a cornerstone to the success of the Danby family of brands. With more than 2 million units manufactured, assembled, and tested annually, Danby manages a global inventory system tracking tens of thousands of raw material items and SKU’s. For more information about Danby Appliances visit www.danby.com

About OES Inc.

Starting in 1980 OES followed a basic strategy that proved successful; connect with emerging companies with market growth opportunities, fill their need for a technology partner and design, produce and support innovative solutions that exceeded expectations and business goals.

It was a strategy that created limitless opportunities for diversity and OES quickly became involved in projects that included electrical engineering as well as assembly, installation, and service for solutions in various markets and industries. As OES engaged with customers around the world and applied their talents to designing innovative electronic and technology applications, their growth and problem solver reputation led to the creation of three diverse yet related divisions – OES Manufacturing, OES Scoreboards and OES Technologies.

Over the years, OES has developed trusted advisor relationships across multiple markets and industries worldwide. OES’ reputation for innovation and rapid prototyping is second only to OES’ reputation for unmatched customer service. Continued success is driven by striving for absolute customer satisfaction and embracing 4F’s – Fast, Focused, Flexible, and Finish – every single day. For more information about OES Inc. visit www.oes-inc.com

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others. Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

About Kontrol Technologies Corp.

Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Technologies provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Technologies Corp. can be found on its website at www.kontrolcorp.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions, and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. Kontrol BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date.  Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

ThreeD Capital $IDK $IDKFF Announces Unaudited March 31, 2021 Net Asset Value Per Share – $1.25

Posted by AGORACOM-JC at 6:20 PM on Thursday, April 15th, 2021
IDK-square-for-blog
  • Announces that at March 31, 2021, its unaudited net asset value per share (“NAV”) was $1.25.

TORONTO, April 15, 2021 — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQB:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, announces that at March 31, 2021, its unaudited net asset value per share (“NAV”) was $1.25.

This announcement is made based on ThreeD’s newly established practice of releasing NAV on a monthly basis as part of the Company’s ongoing response to shareholder interest in receiving periodic information. NAV is calculated based on unaudited month-end financial information.

Use of Non-GAAP Financial Measures:

This press release contains references to NAV or “net asset value per share” which is a non-GAAP financial measure. NAV is calculated as the value of total assets less the value of total liabilities divided by the total number of common shares outstanding as at a specific date. The term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies. There is no comparable GAAP financial measure presented in ThreeD’s consolidated financial statements and thus no applicable quantitative reconciliation for such non-GAAP financial measure. The Company believes that the measure provides information useful to its shareholders in understanding the Company’s performance, and may assist in the evaluation of the Company’s business relative to that of its peers. This data is furnished to provide additional information and does not have any standardized meaning prescribed by GAAP. Accordingly, it should not be considered in isolation or as a substitute for measures of performance prepared in accordance with GAAP, and is not necessarily indicative of other metrics presented in accordance with GAAP. Existing NAV of the Company is not necessarily predictive of the Company’s future performance or the NAV of the Company as at any future date.

About ThreeD Capital Inc.

ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors.  ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company’s ecosystem.

For further information:
Lynn Chapman, CPA, CA
Chief Financial Officer and Corporate Secretary
[email protected]
Phone: 416-941-8900

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Forward-Looking Statements

This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as “forward-looking statements”) within the meaning of Canadian securities laws including, without limitation, statements with respect to the future disclosure of NAV by the Company and the approximate timing thereof. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur including, without limitation, risks relating to the timing and content of future public disclosures by the Company or related to the fact that the term NAV does not have any standardized meaning according to GAAP and therefore may not be comparable to similar measures presented by other companies and may not be indicative of NAV for any future periods. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company’s actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

KWESST $KWE.ca $KWEMF Announces Appointment of VP Operations and Full-Time Engagement of Existing CFO $WRTC $BYRN.ca $PAT.ca $POWW

Posted by AGORACOM-JC at 9:28 AM on Wednesday, April 14th, 2021

  • Announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”).
  • The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.
  • Appointments are part of KWESST’s expanded business plan

Ottawa, Ontario–(April 14, 2021) – KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) (“KWESST” or “the Company”) today announced that it has appointed Rick Bowes, CD, MA, MBA in the new position of Vice President, Operations to oversee and accelerate market introduction of the Company’s products and services for Digitization and Tactical Products (“DTP”). The DTP business unit comprises the bulk of the Company’s current products and services, including TASCS, ATAK integration, the GreyGhostTM micro missile against hostile drones, the laser defence system and the Phantom electronic decoy.

In conjunction, the Company also announced that Steve Archambault, who has been serving as part-time Chief Financial Officer since the Company’s listing in September 2020, will now assume this role on a full-time basis.

“With the expected closing of our recently announced $4 million over-subscribed brokered private placement, KWESST is positioned to execute on an expanded business plan,” said Jeff MacLeod, KWESST Founder, President and CEO. “The appointments announced today add bench strength for accelerated market introduction across our growing portfolio of products and services.”

“We are very pleased indeed to welcome Rick as VP Operations,” added David Luxton, Executive Chairman. “He brings a rare combination of senior defence industry experience and domain knowledge that is directly relevant to our key markets and programs. He also has proven business capture experience and long-standing relationships with major defence contractors. We are equally pleased that Steve Archambault has committed to the Company on a dedicated, full-time basis in the role of CFO.”

About Rick Bowes

Prior to his various senior roles with defence contractors such as General Dynamics Canada, DRS Technologies Canada (now Leonardo DRS), ATCO Frontec and ADGA Group Inc., Rick had a distinguished career as a senior officer in the Canadian Army, retiring in 2003 as a Lieutenant Colonel. He is a graduate of Royal Military College of Canada and served in various operational and staff roles in the Canadian military and on secondment to the British Army. As an armour officer, Rick served with various units such as Lord Strathcona’s Horse (Royal Canadians) and the Canadian Airborne Regiment Battle Group across Canada and in deployed operations in Bosnia-Herzegovina with the UN Protection Force and the NATO Stabilization Force (SFOR). Rick was also part of the planning team for Canada’s participation in the NATO Kosovo Force (KFOR) mission in 1999.

The Company stated that the terms of these appointments include a grant of 300,000 stock options to Rick Bowes, with each stock option being exercisable at a price equal to the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021 on or before April 13, 2026 and a grant of Restricted Share Units (“RSU”s) to Steve Archambault equal to $25,000 divided by the closing price of the Company’s shares on the TSX Venture Exchange on April 16th, 2021.

Read More: https://agoracom.com/ir/Kwesst/forums/discussion/topics/759024-kwesst-announces-appointment-of-vp-operations-and-full-time-engagement-of-existing-cfo/messages/2311873#message

Else $BABY.ca $BABYF Signs Agreement to Expand into 159 Vitamin Cottage Stores Across 20 States $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 8:50 AM on Wednesday, April 14th, 2021
http://blog.agoracom.com/wp-content/uploads/2020/03/else-square-150x150.png
  • Announced that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021

VANCOUVER, BC , April 14, 2021 – ELSE NUTRITION HOLDINGS INC. (TSXV: BABY.V) (OTCQX: BABYF) (FSE: 0YL.F) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , announces that it will expand distribution of it Plant-Based Complete Nutrition for Toddlers into 159 Natural Grocers by Vitamin Cottage stores across 20 states as of May 2021.

“Launching at Natural Grocers by Vitamin Cottage drives significant and strategic distribution for the brand. We are particularly excited by the alignment between this retailer and with our brand, both focusing on helping people through sustainable, organic nutrition solutions, said Hamutal Yitzhak , Else CEO and Co-Founder. “We are eager to bring real, organic and whole food-based, clean label solutions to families in this region,” she added.

About Natural Grocers by Vitamin Cottage

Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) is one of the leading natural food grocers in the US, with 159 stores in 20 states west of the Mississippi river. Founded in 1955, Natural Grocers is an expanding specialty retailer of natural and organic groceries, body care products, and dietary supplements. The products sold by Natural Grocers must meet strict quality guidelines and may not contain artificial colors, flavors, preservatives or sweeteners, or partially hydrogenated or hydrogenated oils. The Company sells only USDA certified organic produce and exclusively pasture-raised, non-confinement dairy products, and free-range eggs. Natural Grocers’ flexible smaller-store format allows it to offer affordable prices in a shopper-friendly, safe, and convenient retail environment. The Company also provides extensive free science-based Nutrition Education programs to help customers make informed health and nutrition choices.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board  members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies,  and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute “forward-looking statements” within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as “will” or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Company’s financial disclosure documents.  Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on management’s perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate.  Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements.  Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management’s expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.